Thal/Dex regimen
WikiDoc Resources for Thal/Dex regimen |
Articles |
---|
Most recent articles on Thal/Dex regimen Most cited articles on Thal/Dex regimen |
Media |
Powerpoint slides on Thal/Dex regimen |
Evidence Based Medicine |
Clinical Trials |
Ongoing Trials on Thal/Dex regimen at Clinical Trials.gov Trial results on Thal/Dex regimen Clinical Trials on Thal/Dex regimen at Google
|
Guidelines / Policies / Govt |
US National Guidelines Clearinghouse on Thal/Dex regimen NICE Guidance on Thal/Dex regimen
|
Books |
News |
Commentary |
Definitions |
Patient Resources / Community |
Patient resources on Thal/Dex regimen Discussion groups on Thal/Dex regimen Patient Handouts on Thal/Dex regimen Directions to Hospitals Treating Thal/Dex regimen Risk calculators and risk factors for Thal/Dex regimen
|
Healthcare Provider Resources |
Causes & Risk Factors for Thal/Dex regimen |
Continuing Medical Education (CME) |
International |
|
Business |
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aparna Vuppala, M.B.B.S. [2]
Synonyms and keywords:Thalidomide-Dexamethasone Regimen
Overview
Thal/Dex regimen refers to a regimen consisting of thalidomide and dexamethasone used for the treatment for multiple myeloma.[1][2]
Regimen
ThalThalidomide
DexDexamethasone
Indications
References
- ↑ 1.0 1.1 Zamagni E, Petrucci A, Tosi P, Tacchetti P, Perrone G, Brioli A; et al. (2012). "Long-term results of thalidomide and dexamethasone (thal-dex) as therapy of first relapse in multiple myeloma". Ann Hematol. 91 (3): 419–26. doi:10.1007/s00277-011-1320-2. PMID 21901342.
- ↑ "NCI Thesaurus".